iCAD INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 13 rows in 2013. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2013-12-12: Reporting owner Burns Kevin C; Form 4; Security Employee Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2013-12-12: Reporting owner Burns Kevin C; Form 4; Security Employee Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2013-10-23: Reporting owner SUSSMAN ELLIOT J MD MBA; Form 4; Security Director Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2013-07-22: Reporting owner SUSSMAN ELLIOT J MD MBA; Form 4; Security Director Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2013-12-12 | Burns Kevin C Officer (Executive VP, CFO and COO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −16,667 33,333 owned after | $2.27 exercise price | 2013-12-16 | |
| 2013-12-12 | Burns Kevin C Officer (Executive VP, CFO and COO) | 4 | Employee Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −8,333 16,667 owned after | $2.90 exercise price | 2013-12-16 | |
| 2013-10-23 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +1,737 1,737 owned after | $10.02 exercise price | 2013-10-25 | |
| 2013-07-22 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,192 3,192 owned after | $6.20 exercise price | 2013-07-23 | |
| 2013-04-22 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,418 4,418 owned after | $4.46 exercise price | 2013-05-08 | |
| 2013-01-22 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,090 2,090 owned after | $5.15 exercise price | 2013-01-24 | |
| 2013-01-22 | SUSSMAN ELLIOT J MD MBA Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,300 4,300 owned after | $5.15 exercise price | 2013-01-24 | |
| 2013-01-22 | Subramaniam Somu Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,300 4,300 owned after | $5.15 exercise price | 2013-01-24 | |
| 2013-01-22 | Klein Michael S Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,300 4,300 owned after | $5.15 exercise price | 2013-01-24 | |
| 2013-01-22 | RAPPAPORT STEVEN N Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,300 4,300 owned after | $5.15 exercise price | 2013-01-24 | |
| 2013-01-22 | HOWARD DR LAWRENCE Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,300 4,300 owned after | $5.15 exercise price | 2013-01-24 | |
| 2013-01-22 | Ecock Anthony F Director | 4 | Director Stock Option (right to buy( Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,300 4,300 owned after | $5.15 exercise price | 2013-01-24 | |
| 2013-01-22 | Brem Rachel Director | 4 | Director Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +4,300 4,300 owned after | $5.15 exercise price | 2013-01-24 |